Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05934071
What this trial is testing

Effects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF.

Who this might be right for
Heart FailureVentricular RemodelingVentricular Dysfunction
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 160
Not applicableNot Yet RecruitingNCT07334145
What this trial is testing

Effect of SGLT2 Inhibitors on Anemic CKD Patients

Who this might be right for
Anemia in CKD Patients
Sohag University 60
Post-approval studies (Phase 4)Study completedNCT03977116
What this trial is testing

Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients

Who this might be right for
Diabetes MellitusHeart FailureVentricular Arrythmia
University of Campania Luigi Vanvitelli 100
Testing effectiveness (Phase 2)Study completedNCT00642278
What this trial is testing

An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type IIDiabetes Mellitus, Non Insulin Dependent
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 451
Testing effectiveness (Phase 2)Study completedNCT03713190
What this trial is testing

Effects of Empagliflozin on Endogenous Glucose Production in End Stage Renal Disease(ESRD).

Who this might be right for
End Stage Renal Disease
University of Pisa 25
Not applicableEnrolling By InvitationNCT05029115
What this trial is testing

The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus

Who this might be right for
SGLT-2 InhibitorAtrial FibrillationDiabetes Mellitus, Type 2
Ewha Womans University Mokdong Hospital 716
Not applicableActive Not RecruitingNCT07694596
What this trial is testing

SGLT2 Inhibitors and Cognitive Function in Adults With Type 2 Diabetes (SaveMinD)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Cognitive Dysfunction
University of Primorska 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07060417
What this trial is testing

Vascular Effects of SGLT2i in Non-diabetic CKD

Who this might be right for
Non-diabetic Chronic Kidney Disease
VA Office of Research and Development 52
Post-approval studies (Phase 4)WithdrawnNCT04531397
What this trial is testing

Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease

Who this might be right for
ProteinuriaChronic Kidney Diseases
Children's Hospital of Fudan University
Not applicableUnknownNCT02284269
What this trial is testing

Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Pharmaceuticals and Medical Devices Agency, Japan 18,000
Not applicableNot Yet RecruitingNCT07441187
What this trial is testing

Efficacy and Safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese Patients With Type 2 Diabetes Mellitus

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 300
Post-approval studies (Phase 4)Study completedNCT06825156
What this trial is testing

Metabolic and Renal Outcomes in Cardiac Surgery Patients Receiving SGLT2 Inhibitors

Who this might be right for
Acute Kidney Injury
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 60
Large-scale testing (Phase 3)Study completedNCT06690723
What this trial is testing

Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep Apnea
University Malaysia Sarawak 160
Testing effectiveness (Phase 2)Study completedNCT03316131
What this trial is testing

Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA

Who this might be right for
Asymptomatic Hyperuricemia
AstraZeneca 36
Post-approval studies (Phase 4)Not Yet RecruitingNCT07436663
What this trial is testing

Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC

Who this might be right for
Breast Cancer
Tanta University 150
Not applicableStudy completedNCT07302464
What this trial is testing

Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease Patients

Who this might be right for
Sodium Glucose Co-Transporter 2 InhibitorsEstimated Glomerular Filtration RateDiabetes+1 more
Ain Shams University 60
Not applicableStudy completedNCT02636192
What this trial is testing

Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 200,000
Not applicableStudy completedNCT03510000
What this trial is testing

Alleviating Carbohydrate-Counting Burden in T1DM Using Artificial Pancreas and Empagliflozin

Who this might be right for
Type1diabetes
Samuel Lunenfeld Research Institute, Mount Sinai Hospital 30
Post-approval studies (Phase 4)Study completedNCT02796170
What this trial is testing

Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesHypertension
Tulane University School of Medicine 11
Large-scale testing (Phase 3)Study completedNCT06117137
What this trial is testing

The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus

Who this might be right for
Fatty Liver, Nonalcoholic
Sohag University 150
Next Page